US to Allow Asylum Denials on Public Health Grounds Under New Trump-Era Rule

President Trump Signals Imminent Cuba Action While Prioritizing Iran Conflict Resolution

The U.S. government has finalized a controversial immigration regulation that could let authorities deny asylum to migrants by citing public health risks, a move critics say revives pandemic-era powers and may further restrict access to refuge at the southern border.

The regulation, first drafted during the COVID-19 pandemic under President Donald Trump’s administration, was finalized and published in the Federal Register this week and will take effect soon. It gives U.S. officials broad authority to deny asylum applications if a migrant is deemed to pose an “emergency public health concern” due to a communicable disease.

Although the rule is unlikely to have an immediate impact, it adds a new tool to the Trump administration’s arsenal for turning away would-be asylum seekers at the U.S.–Mexico border. Federal authorities say the measure is intended to safeguard public health, but opponents argue it could be used to justify sweeping denials of asylum claims even outside active health emergencies.

During the early stages of the COVID-19 pandemic, Trump’s government invoked a public health authority under Title 42 to rapidly expel migrants without standard asylum processing. The policy remained in place until 2023, even after President Joe Biden succeeded Trump, because legal challenges complicated efforts to end it. Critics have long said Title 42 was misused to circumvent asylum laws intended to protect vulnerable migrants.

Under the new regulation, authorities can cite a communicable disease as grounds for blocking asylum if they determine a migrant poses a public health threat. This extends beyond individuals showing active symptoms and could include people coming from regions where outbreak conditions exist, according to media coverage of the published rule.

Supporters of the regulation argue it gives border officials clearer tools to manage public health risks tied to migration, particularly in future health emergencies. They contend the rule complements broader efforts to control the flow of migrants and ensure that health considerations are integrated into immigration decisions.

Opposition has been swift. Immigration advocates and policy experts say using health concerns as a basis to deny asylum could undermine longstanding international and U.S. legal protections for refugees fleeing persecution and violence. They also worry the policy’s broad language could be applied arbitrarily against migrants based on subjective assessments of risk rather than scientific evidence.

Under existing U.S. law, asylum seekers are eligible for protection if they can show they face persecution in their home countries due to race, religion, nationality, membership in a particular social group, or political opinion. The new rule adds public health as a factor that could override these criteria, a change critics fear could narrow access to asylum for many deserving applicants.

The Biden administration delayed implementation of the regulation multiple times, pushing back its effective date on five occasions. It has stopped short of repealing the policy, leaving its implementation in motion under the current administration.

In addition to asylum, the rule applies to “withholding of removal,” a form of protection that blocks deportation when a person faces a significant risk of torture or harm if returned to their home country. This expands the reach of public health considerations into other humanitarian protections.

Border authorities have already seen illegal entries drop to decades-low levels since Trump returned to the White House, thanks in part to multiple restrictive immigration policies. Adding a public health denial mechanism could further reduce asylum claims, though legal challenges are likely to emerge once the rule is fully implemented.

As the rule begins to take effect, its implications for asylum seekers, immigration courts, and federal agencies remain closely watched. Advocates argue that public health tools should be based on science and used sparingly, while policymakers promoting the change emphasize national health and security priorities.